Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow Nov 17, 2022
Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense Oct 4, 2022
Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow Aug 18, 2022
Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan Jun 30, 2022
